---
document_datetime: 2023-09-21 20:36:52
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/maviret-epar-all-authorised-presentations_en.pdf
document_name: maviret-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.7287862
conversion_datetime: 2025-12-25 03:52:10.280264
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength       | Pharmaceutical form       | Route of administration   | Immediate Packaging        | Pack size           |
|------------------|-------------------|----------------|---------------------------|---------------------------|----------------------------|---------------------|
| EU/1/17/1213/001 | Maviret           | 100 mg / 40 mg | Film-coated tablet        | Oral use                  | blister (PVC/PE/PCTFE/alu) | 84 (4 x 21) tablets |
| EU/1/17/1213/003 | Maviret           | 50 mg / 20 mg  | Coated granules in sachet | Oral use                  | sachet (PET/alu/PE)        | 28 sachets          |